This is an overview of the USAID/Burma FY 2022 Tuberculosis (TB) Roadmap, implemented with FY 2021 budget

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for Burma that will be used for the implementation of Burma’s FY 2022 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of Burma’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for Burma per Technical Area

Technical AreaUSAID TB budget for FY22USAID Percentage of TB budget for FY22
REACH$5,377,0045%
CURE$4,315,00036%
PREVENT$1,100,0009%
SUSTAINABLE SYSTEMS$1,208,00010%
TOTAL BUDGET:$12,000,000100%

Table 2: TB Core Indicators in Burma from 2015-2020 and Targets from 2021-2022

#Name2015201620172018201920202021*2022*
REACH: Increased DS- and DR-TB case notification
1TB Detection67.2%69.5%69.0%76.2%77.0%61.9%UNGA target: 147,400UNGA target: 136,900
2Bacteriological Diagnosis Coverage (Pulmonary TB)38.5%40.7%40.8%44.1%45.0%50.0%
3Childhood TB Notifications34,93031,63328,72326,26223,70313,244UNGA target: 33,400UNGA target: 31,600
4Drug-Resistant TB Notifications2,8043,2133,309

3,514

3,2322,368UNGA target: 9,700UNGA target: 10,100
5Private Sector TB NotificationsTBDTBDTBD48,70344,52220,363
6Contact Investigation Coverage**TBDTBDTBDTBDTBDTBDTBDTBD
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate***87.4%87.7%87.2%88%88%
8Drug-Resistant TB treatment Success Rate****79.5%79.3%79.0%78%
PREVENT: Prevent TB transmission and development
9TPT Coverage3,3611,0186,8685,77610,5912,139UNGA target: 123,750UNGA target: 146,050
SUSTAINABLE SYSTEMS: Commitment and sustainability
10Proportion of Domestic Financing for TB6.7%6.5%9.0%

*Projected Targets: These represent the United Nations General Assembly High-Level Meeting targets (UNGA targets).
**Contact Investigation Coverage: 
Currently data not available or very limited.
***TB Treatment Success Rate: newest data for 2019 cohort reported.
****Drug-Resistant TB Treatment Success Rate: newest data for 2018 cohort reported.